The time has finally been announced at ClinicalTrials.gov that the Hemopurifier of Aethlon Medical will start the trial in November.
After watching their balance sheet straightening with all other announcements in the past six months, one would come to the conclusion that valuation should start its long awaited upward climb.
At this point, I am happy as a long time investor.
Aethlon's opportunity is here. Valuation will come.
But most important, people who are suffering will have the opportunity for health.
Good Luck to one and all.